Vyne Therapeutics
1 known investors
Vyne Therapeutics is a biopharmaceutical company developing treatments for Graves' disease and thyroid eye disease (TED). Its lead candidate is designed to block the interaction of autoantibodies with the TSH receptor to interrupt the disease mechanism.
Investors · 1
In the news
Frequently asked questions
- What does Vyne Therapeutics do?
- Vyne Therapeutics is a biopharmaceutical company developing treatments for Graves' disease and thyroid eye disease (TED). Its lead candidate is designed to block the interaction of autoantibodies with the TSH receptor to interrupt the disease mechanism.
- Who are Vyne Therapeutics's investors?
- Vyne Therapeutics's investors include F-Prime Capital.